Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...
DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...
Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately ...
Artificial intelligence (AI) programs have recently acquired widespread popularity in dermatology for assessing, diagnosing, and treating skin conditions. As reported in the International Journal of ...
In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...
Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.
By measuring bioimpedance, the patch can help identify “abnormal” areas that may require ... Each participant had the patch ...
For years, detecting skin cancer often meant undergoing a biopsy, an invasive procedure that can cause anxiety for patients and take time to yield results. But with the Dermagraphix, a cutting-edge ...
Using cutting-edge bioinformatics techniques for gene identification and sequencing, researchers are comprehensively mapping signaling pathway distributions in both normal and acne-affected skin. Acne ...
A woman soaks up the sun. (Oleksandr P:, Oleksandr P: via Pexels.) The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in ...
Atrophy: Atrophy is a skin depression resulting from thinned epidermis and/or dermis. Topical-steroid-induced striae (striae distensae). These marks are a dose-, vehicle-, time-, and ...